Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | coagulation factor II (thrombin) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.1771 | 1 |
Trichomonas vaginalis | cdc25b, putative | 0.0167 | 0.1771 | 0.5 |
Schistosoma mansoni | m-phase inducer phosphatase(cdc25) | 0.0167 | 0.1771 | 0.5 |
Entamoeba histolytica | rodhanase-like domain containing protein | 0.0167 | 0.1771 | 0.5 |
Trichomonas vaginalis | m-phase inducer phosphatase, putative | 0.0167 | 0.1771 | 0.5 |
Trichomonas vaginalis | cdc25c, putative | 0.0167 | 0.1771 | 0.5 |
Onchocerca volvulus | 0.0167 | 0.1771 | 0.5 | |
Trypanosoma brucei | 3', 5'-cyclic nucleotide phosphodiesterase, putative | 0.0228 | 1 | 0.5 |
Trichomonas vaginalis | mitotic inducer phosphatase CDC25, putative | 0.0167 | 0.1771 | 0.5 |
Entamoeba histolytica | rodhanase-like domain containing protein | 0.0167 | 0.1771 | 0.5 |
Trichomonas vaginalis | mitotic inducer phosphatase CDC25, putative | 0.0167 | 0.1771 | 0.5 |
Onchocerca volvulus | 0.0167 | 0.1771 | 0.5 | |
Trichomonas vaginalis | mitotic inducer phosphatase CDC25, putative | 0.0167 | 0.1771 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.1771 | 1 |
Trichomonas vaginalis | cdc25b, putative | 0.0167 | 0.1771 | 0.5 |
Entamoeba histolytica | rodhanase-like domain containing protein | 0.0167 | 0.1771 | 0.5 |
Trypanosoma cruzi | cyclic nucleotide phosphodiesterase | 0.0228 | 1 | 0.5 |
Echinococcus multilocularis | m phase inducer phosphatase(cdc25) | 0.0167 | 0.1771 | 0.5 |
Onchocerca volvulus | 0.0167 | 0.1771 | 0.5 | |
Brugia malayi | Rhodanese-like domain containing protein | 0.0167 | 0.1771 | 0.5 |
Onchocerca volvulus | 0.0167 | 0.1771 | 0.5 | |
Trichomonas vaginalis | m-phase inducer phosphatase, putative | 0.0167 | 0.1771 | 0.5 |
Echinococcus granulosus | m phase inducer phosphatasecdc25 | 0.0167 | 0.1771 | 0.5 |
Brugia malayi | Rhodanese-like domain containing protein | 0.0167 | 0.1771 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
2x APTT (functional) | uM | Concentration needed to double the activated partial thromboplastin time in human plasma | ChEMBL. | 14505652 |
2x APTT (functional) | ND 0 uM | Concentration needed to double the activated partial thromboplastin time in human plasma | ChEMBL. | 14505652 |
Ki (binding) | = 250 nM | Inhibitory potency against human thrombin | ChEMBL. | 15163182 |
Ki (binding) | = 250 nM | Inhibitory constant evaluated against thrombin (Factor IIa) | ChEMBL. | 14505652 |
Ki (binding) | = 250 nM | Inhibitory potency against human thrombin | ChEMBL. | 15163182 |
Ki (binding) | = 250 nM | Inhibitory constant evaluated against thrombin (Factor IIa) | ChEMBL. | 14505652 |
Ki (binding) | = 89000 nM | Inhibitory constant evaluated against trypsin | ChEMBL. | 14505652 |
Ki (binding) | = 89000 nM | Inhibitory constant evaluated against trypsin | ChEMBL. | 14505652 |
Selectivity ratio (binding) | = 356 | Ratio of inhibitory constant evaluated against trypsin to that of thrombin (Factor IIa) | ChEMBL. | 14505652 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.